<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34380534</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1172</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>Orphanet journal of rare diseases</Title><ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation></Journal><ArticleTitle>Progressive spastic tetraplegia and axial hypotonia (STAHP) due to SOD1 deficiency: is it really a new entity?</ArticleTitle><Pagination><StartPage>360</StartPage><MedlinePgn>360</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">360</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-021-01993-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic Lateral Sclerosis (ALS) is a rare, progressive, and fatal neurodegenerative disease due to upper and lower motor neuron involvement with symptoms classically occurring in adulthood with an increasing recognition of juvenile presentations and childhood neurodegenerative disorders caused by genetic variants in genes related to Amyotrophic Lateral Sclerosis. The main objective of this study is detail clinical, radiological, neurophysiological, and genetic findings of a Brazilian cohort of patients with a recent described condition known as Spastic Tetraplegia and Axial Hypotonia (STAHP) due to SOD1 deficiency and compare with other cases described in the literature and discuss whether the clinical picture related to SOD1 protein deficiency is a new entity or may be represent a very early-onset form of Amyotrophic Lateral Sclerosis.</AbstractText><AbstractText Label="METHODS">We conducted a case series report which included retrospective data from five Brazilian patients with SOD1 protein deficiency of a Brazilian reference center for Neuromuscular Disorders. Clinical data were obtained from a review of the medical records and descriptive statistics and variables were summarized using counts and percentages of the total population.</AbstractText><AbstractText Label="RESULTS">All 5 patients presented with a childhood-onset neurodegenerative disorders characterized by spastic tetraplegia with axial hypotonia in all cases, with gestational history showing polyhydramnios in 4/5 and intrauterine growth restriction in 3/5 patients, with most patients initially presenting a normal motor development until the six month of life or during the first year followed by a rapidly progressive motor decline with severe dysphagia and respiratory insufficiency in all patients accompanied by cognitive impairment in 3/5 patients. All patients were homozygous for the c.335dupG (p.Cys112Trpfs*11) mutation in the SOD1 gene with completely decreased enzyme activity.</AbstractText><AbstractText Label="CONCLUSIONS">This case series is the biggest data collection of the new recent clinical entity described as Spastic Tetraplegia and Axial Hypotonia (STAHP) due to SOD1 deficiency.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>Paulo Victor Sgobbi</ForeName><Initials>PVS</Initials><Identifier Source="ORCID">0000-0002-7416-7108</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil. pvsgobbi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Wladimir Bocca Vieira de Rezende</ForeName><Initials>WBVR</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farias</LastName><ForeName>Igor Braga</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badia</LastName><ForeName>Bruno de Mattos Lombardi</ForeName><Initials>BML</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Icaro Fran&#xe7;a Navarro</ForeName><Initials>IFN</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Gustavo Carvalho</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marin</LastName><ForeName>Carolina Maria</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos Jorge</LastName><ForeName>Ana Carolina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souto</LastName><ForeName>Em&#xed;lia Correia</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serrano</LastName><ForeName>Paulo de Lima</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Roberta Ismael Lacerda</ForeName><Initials>RIL</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chieia</LastName><ForeName>Marco Ant&#xf4;nio Troccoli</ForeName><Initials>MAT</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertini</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Ges&#xf9; Children's Research Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Acary Souza Bulle</ForeName><Initials>ASB</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Federal University of S&#xe3;o Paulo (UNIFESP), Emba&#xfa; Street, 67, Vila Clementino, S&#xe3;o Paulo, SP, 04039-060, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Orphanet J Rare Dis</MedlineTA><NlmUniqueID>101266602</NlmUniqueID><ISSNLinking>1750-1172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009123" MajorTopicYN="Y">Muscle Hypotonia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011782" MajorTopicYN="N">Quadriplegia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Childhood neurodegenerative disorder</Keyword><Keyword MajorTopicYN="N">Hypotonia</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Neuromuscular disorders</Keyword><Keyword MajorTopicYN="N">Progressive spastic tetraplegia</Keyword><Keyword MajorTopicYN="N">SOD1 deficiency</Keyword><Keyword MajorTopicYN="N">SOD1 mutation</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34380534</ArticleId><ArticleId IdType="pmc">PMC8359534</ArticleId><ArticleId IdType="doi">10.1186/s13023-021-01993-0</ArticleId><ArticleId IdType="pii">10.1186/s13023-021-01993-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eleutherio ECA, Magalh&#xe3;es RSS, Brasil AA, Neto JRM, Paranhos LH. SOD1, more than just an antioxidant. Arch Biochem Biophys. 2021;697:108701. doi: 10.1016/j.abb.2020.108701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2020.108701</ArticleId><ArticleId IdType="pubmed">33259795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ, McKeown SR, Rashid S. Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene. 2016;577(2):109&#x2013;118. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Henati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza PVS, Pinto WBVR, Chieia MAT, Oliveira ASB. Clinical and genetic basis of familial amyotrophic lateral sclerosis. Arq Neuropsiquiatr. 2015;73(12):1026&#x2013;1037. doi: 10.1590/0004-282X20150161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20150161</ArticleId><ArticleId IdType="pubmed">26465287</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Nodrstr&#xf6;m U, Tsiakas K, Johannsen J, Volk AE, Bierhals T, et al. Phenotype in an infant with SOD1 homozygous truncating mutation. N Engl J Med. 2019;381(5):486&#x2013;488. doi: 10.1056/NEJMc1905039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1905039</ArticleId><ArticleId IdType="pubmed">31314961</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Elpers C, Reunert J, McCormick ML, Mohr J, Biskup S, et al. SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis. Brain. 2019;142(8):2230&#x2013;2237. doi: 10.1093/brain/awz182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz182</ArticleId><ArticleId IdType="pmc">PMC6658856</ArticleId><ArticleId IdType="pubmed">31332433</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto WBVR, Naylor FGM, Chieia MAT, Souza PVS, Oliveira ASB. New findings in facial-onset sensory and motor neuronopathy (FOSMN) syndrome. Rev Neurol (Paris) 2019;175(4):238&#x2013;246. doi: 10.1016/j.neurol.2018.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2018.04.010</ArticleId><ArticleId IdType="pubmed">30293881</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz JM, Cooper DN, Schuelke M, et al. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361&#x2013;362. doi: 10.1038/nmeth.2890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2890</ArticleId><ArticleId IdType="pubmed">24681721</ArticleId></ArticleIdList></Reference><Reference><Citation>Adzhubei IA, Schmidt S, Peshkin L, Seelow D. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248&#x2013;249. doi: 10.1038/nmeth0410-248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth0410-248</ArticleId><ArticleId IdType="pmc">PMC2855889</ArticleId><ArticleId IdType="pubmed">20354512</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem. 1989;179(1):8&#x2013;18. doi: 10.1016/0003-2697(89)90192-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(89)90192-9</ArticleId><ArticleId IdType="pubmed">2547324</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitz DR, Oberley LW. Measurement of MnSOD and CuZnSOD activity in mammalian tissue homogenates. Curr Protoc Toxicol. 2001 doi: 10.1002/0471140856.tx0705s08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471140856.tx0705s08</ArticleId><ArticleId IdType="pubmed">20954153</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMauro S, Serviei S, Zeviani M, DiRocco M, DeVivo DC, DiDonato S, et al. Cytochrome c oxidase deficiency in Leigh Syndrome. Ann Neurol. 1987;22(4):498&#x2013;506. doi: 10.1002/ana.410220409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410220409</ArticleId><ArticleId IdType="pubmed">2829705</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldnik JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza PV, Pinto WB, Oliveira AS. C9orf72-related disorders: expanding the clinical and genetic spectrum of neurodegenerative diseases. Arq Neuropsiquiatr. 2015;73(3):246&#x2013;256. doi: 10.1590/0004-282X20140229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20140229</ArticleId><ArticleId IdType="pubmed">25807132</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, et al. Phase 1&#x2013;2 trial of antisense oligonuleotide tofersen for SOD1 ALS. N Engl J Med. 2020;383(2):109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Berry JD, McKenna-Yasek DM, Gernoux G, Owegi MA, Pothier LM, et al. SOD1 suppression with adeno-associated virus and MicroRNA in familial ALS. N Engl J Med. 2020;383(2):151&#x2013;158. doi: 10.1056/NEJMoa2005056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2005056</ArticleId><ArticleId IdType="pubmed">32640133</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C. SOD1 in amyotrophic lateral sclerosis: &#x201c;ambivalent&#x201d; behavior connected to the disease. Int J Mol Sci. 2018;19(5):1345. doi: 10.3390/ijms19051345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId><ArticleId IdType="pmc">PMC5983710</ArticleId><ArticleId IdType="pubmed">29751510</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S, Heath PR, Kirby J, et al. Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant, defenses, and nitric oxide synthetic pathways. J Biol Chem. 2003;278(8):6371&#x2013;6383. doi: 10.1074/jbc.M209915200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209915200</ArticleId><ArticleId IdType="pubmed">12475980</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, Chapman AL, Tennant ME, Wharton SB, Cookson MR, Menzies FM, et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet. 2007;16(22):2720&#x2013;2728. doi: 10.1093/hmg/ddm226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm226</ArticleId><ArticleId IdType="pmc">PMC4516806</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7(9):710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Orban P, Devon RS, Hayden MR, Leavitt BR. Chapter 15 Juvenile amyotrophic lateral sclerosis. Handb Clin Neurol. 2007;82:301&#x2013;312. doi: 10.1016/S0072-9752(07)80018-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0072-9752(07)80018-2</ArticleId><ArticleId IdType="pubmed">18808900</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z-J, Lin H-X, Liu G-L, Tao Q-Q, Ni W, Xiao B-G, et al. The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin Genet. 2017;92(3):267&#x2013;273. doi: 10.1111/cge.13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13015</ArticleId><ArticleId IdType="pubmed">28429524</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto WBVR, Debona R, Nunes PP, Assis ACD, Lopes CG, Bortholin T, et al. Atypical motor neuron disease variants: still a diagnostic challenge in neurology. Rev Neurol (Paris) 2019;175(4):221&#x2013;232. doi: 10.1016/j.neurol.2018.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2018.04.016</ArticleId><ArticleId IdType="pubmed">30846210</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonhsen B. Diagnostic criteria for amyotrophic lateral sclerosis from EL escorial to gold coast. Clin Neurophysiol. 2020;131(8):1962&#x2013;1963. doi: 10.1016/j.clinph.2020.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.012</ArticleId><ArticleId IdType="pubmed">32418823</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR, Cui LY, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsugawa J, Dharmadasa T, Ma Y, Huynh W, Vucic S, Kiernan MC. Fasciculation intensity and disease progression in amyotrophic lateral sclerosis. Clin Neurophysiol. 2018;129(10):2149&#x2013;2154. doi: 10.1016/j.clinph.2018.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.07.015</ArticleId><ArticleId IdType="pubmed">30114663</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowser R, Turner MR, Shefner J. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat Rev Neurol. 2011;7(11):631&#x2013;638. doi: 10.1038/nrneurol.2011.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.151</ArticleId><ArticleId IdType="pubmed">21989244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmann M, von Kleist-Retzow JC, Haupt WF, Herkenrath P, Schauseil-Zipf U. Diagnostic value of electromyography in children and adolescents. J Clin Neurophysiol. 2005;22:43&#x2013;48. doi: 10.1097/01.WNP.0000151146.91147.A1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.WNP.0000151146.91147.A1</ArticleId><ArticleId IdType="pubmed">15689712</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer RJ, Brown MJ, Berman PH. The diagnostic value of electromyography in infantile hypotonia. Am J Dis Child. 1982;136(12):1057&#x2013;1059.</Citation><ArticleIdList><ArticleId IdType="pubmed">7148759</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetin E, Cuisset JM, Tiffreau V, Vall&#xe9;e L, Hurtevent JF, Thevenon A. The value of electromyography in the aetiological diagnosis of hypotonia in infants and toddlers. Ann Phys Rehabil Med. 2009;52:546&#x2013;555. doi: 10.1016/j.rehab.2009.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rehab.2009.06.004</ArticleId><ArticleId IdType="pubmed">19713169</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Restagno G, Stewart HG, Chi&#xf2; A. Disease penetrance in amyotrophic lateral sclerosis associated with mutations in the SOD1 gene. Ann Neurol. 2004;55(2):298&#x2013;299. doi: 10.1002/ana.10850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10850</ArticleId><ArticleId IdType="pubmed">14755739</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RH, Fisher EM, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136(Pt 8):2342&#x2013;2358. doi: 10.1093/brain/awt097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt097</ArticleId><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo M. Clinical approach to neurodegenerative disorders in childhood: an updated overview. Acta Neurol Belg. 2019;119(4):511&#x2013;521. doi: 10.1007/s13760-019-01160-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-019-01160-0</ArticleId><ArticleId IdType="pubmed">31161467</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>